EVOFEM BIOSCIENCES, INC. Cash and Restricted Cash
EVOFEM BIOSCIENCES, INC. (EVFM) had Cash and Restricted Cash of $285.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $285.00K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.38M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $578.00K.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $840.00K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $285.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $2.38M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $578.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $840.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $748.00K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $1.11M 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $741.00K 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $722.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $692.00K 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $689.00K 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $580.00K 10-K · filed 2026-03-11 | |
| 2023-09-30 | $410.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $636.00K 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $1.53M 10-Q · filed 2024-05-15 | |
| 2022-12-31 | $4.78M 10-K · filed 2025-03-24 | |
| 2022-09-30 | $9.84M 10-Q · filed 2023-01-06 | |
| 2022-06-30 | $22.27M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $7.73M 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $13.59M 10-K · filed 2024-03-27 | |
| 2021-09-30 | $25.04M 10-Q · filed 2023-01-06 | |
| 2021-06-30 | $62.99M 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $65.09M 10-Q · filed 2022-05-10 | |
| 2020-12-31 | $72.25M 10-K · filed 2023-04-27 | |
| 2020-09-30 | $87.83M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $124.56M 10-Q · filed 2021-08-11 | |
| 2020-03-31 | $10.02M 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $16.63M 10-K · filed 2022-03-10 | |
| 2019-09-30 | $32.51M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $51.08M 10-Q · filed 2020-08-04 | |
| 2019-03-31 | $600.00K 10-Q · filed 2020-05-06 | |
| 2018-12-31 | $1.76M 10-K · filed 2021-03-04 | |
| 2018-09-30 | $12.52M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $23.34M 10-Q · filed 2019-08-06 | |
| 2018-03-31 | $5.60M 10-Q · filed 2019-05-07 | |
| 2017-12-31 | $1.70M 10-K · filed 2020-03-12 | $3.51M 10-K · filed 2018-02-26 |
| 2017-09-30 | $4.17M 10-Q · filed 2018-11-07 | $5.84M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.55M 10-Q · filed 2018-08-02 | |
| 2017-03-31 | $5.09M 10-Q · filed 2018-05-14 | |
| 2016-12-31 | $11.49M 8-K/A · filed 2018-04-06 | $11.68M 10-Q · filed 2017-11-08 |
| 2016-09-30 | $14.56M 10-Q · filed 2017-11-08 | |
| 2015-12-31 | $37.95M 10-K · filed 2018-02-26 | |
| 2014-12-31 | $75.95M 10-K · filed 2018-02-26 |